AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BioPort working on new vaccine.(Brief Article)
2002 APR 10 - (NewsRx.com & NewsRx.net) -- An estimated 20 companies, federal organizations and universities are working toward finding a new anthrax vaccine.
So is BioPort Corp., the Lansing, Michigan, company that now is the sole U.S. provider of the existing vaccine. BioPort has worked on a new anthrax vaccine for the past year. Other researchers began as early as 1997.
One of the potential competitors might be ready for human safety trials this summer, but all are likely years away from approval for use.
BioPort just this year received U.S. Food and Drug Administration approval for its renovated labs that make a relatively old, slow-acting vaccine against anthrax. For 4 years, the company was unable to ship the vaccine.
Now, it knows a new anthrax vaccine could make its vaccine obsolete. So it, too, has joined the hunt for alternatives.
Its new vaccine could be administered through a nasal spray. And it could take effect after three doses given during a 2-3 month period - much faster than the current drug.
"Based on the experience of the past three years, we're in a unique position," BioPort spokeswoman Kim Brennen Root told the Lansing State Journal. "We have every intention of moving forward with a next-generation vaccine candidate."
- New combination vaccine may fight malaria.(research produces a new vaccine that...
- Magazine article from: Science News Helmuth L. February 20, 1999 700+ words
...Control and Prevention (CDC) in Atlanta. Lal and his colleagues report their work on the new vaccine in the Feb. 16 Proceedings of the National Academy of Sciences. "Even if you have 99 percent protection against one stage, the one or two...
- BioPort working on new vaccine.
- Newspaper article from: TB & Outbreaks Week April 9, 2002 700+ words
...the hunt for alternatives. Its new vaccine could be administered through a...a report issued by the U.S. National Academy of Sciences. But it requires 6...will resume the program. But a new vaccine could have broader use in the wake...
- Dual Action Anthrax Vaccine More Effective Than Current Vaccine in Early Tests;...
- News wire article from: Ascribe Higher Education News Service September 1, 2003 700+ words
...defensive weapon against bioterrorism. The new vaccine prods the immune system to attack both...The researchers suggest that the new vaccine will also be an important tool for treating...addition to protective antigen, the new vaccine incorporates capsular poly-gamma...
- New vaccine requirements aimed at Nevada's high rate of hepatitis.
- Newspaper article from: Hepatitis Weekly August 5, 2002 700+ words
...hepatitis B is not linked to the development of multiple sclerosis or other nerve diseases. The institute is an arm of the National Academy of Sciences, a private organization chartered by Congress to provide advice to the government on scientific matters...
- New Vaccine Could Strike Double Blow to Anthrax.
- Newspaper article from: Knight Ridder/Tribune Business News September 2, 2003 700+ words
...were given four times the lethal dose of anthrax toxin survived, the Harvard researchers report in the Proceedings of the National Academy of Sciences. Their goal is to develop a vaccine that is more effective, has fewer side effects and is easier to give...
- New Vaccine Strategy Targets Tumor Growth Factors With Gene Therapy.
- Newspaper article from: Angiogenesis Weekly November 2, 2001 700+ words
...tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen, Proceedings of the National Academy of Sciences USA, September 2001;98(20):11545-11550). By depleting mice of CD4[superscript]+ T lymphocytes...
- New vaccine requirements aimed at Nevada's high rate of hepatitis.(Brief...
- Newspaper article from: Vaccine Weekly August 7, 2002 700+ words
...hepatitis B is not linked to the development of multiple sclerosis or other nerve diseases. The institute is an arm of the National Academy of Sciences, a private organization chartered by Congress to provide advice to the government on scientific matters...
- New Vaccine Targets for Influenza and Research Discovered by Pure Vaccine...
- Press release article from: Business Wire May 12, 2009 700+ words
...vaccine candidates that are conserved among virus strains. These results were published January 2009 in Proceedings of the National Academy of Sciences (PNAS). Using its proprietary discovery technology, Dr. Hildebrand's team identified a discrete set...
